Innovation Portfolio
Freeway
Balloon catheters and specialty devices engineered for improved and predictable coronary intervention.
Designed for physicians who demand performance, control, and reliability.
Explore our coronary and innovation portfolios — each product developed through clinical feedback and rigorous R&D to support complex PCI procedures worldwide.
Coronary Portfolio
Balloon Catheters
Semi-compliant, non-compliant and ultra high-compliant dilatation catheters for coronary intervention.
Semi-Compliant Dilatation
Evolve-Pro 1.0-1.5mm
FDA SOON- Semi-compliant balloon catheter for small-vessel coronary intervention.
- Designed for precise lesion preparation across the 1.0–1.5 mm size range.
- Supports predictable dilatation performance in complex anatomy.
Expanded Size Range
Evolve-Pro 1.75-4.0mm
FDA SOON- Semi-compliant balloon catheter covering 1.75–4.0 mm diameters.
- Enables physicians to address a broad range of coronary lesions.
- Part of the Evolve-Pro next-generation PTCA catheter platform.
High-Pressure Dilatation
Gambit-Nc 2.0-4.0mm
- Non-compliant balloon catheter for resistant lesion dilatation.
- Delivers high nominal pressure performance when compliance must be controlled.
- Supports effective preparation in calcified and fibrotic lesions.
Next-Generation Compliance
Gambit-NC35 (2.0-4.0mm)
Coming SOON- Ultra high-compliant balloon catheter for advanced coronary applications.
- Expanding the Gambit-NC platform with enhanced compliance characteristics.
- Currently in development — contact us for availability updates.
Coronary Portfolio Overview
- Evolve-Pro 1.0-1.5mm
- Semi-Compliant · FDA SOON
- Evolve-Pro 1.75-4.0mm
- Semi-Compliant · FDA SOON
- Gambit-Nc 2.0-4.0mm
- Non-Compliant
- Gambit-NC35 (2.0-4.0mm)
- Ultra High-Compliant · Coming SOON
Innovation Portfolio
Speciality Portfolio
Innovative specialty devices for complex PCI and advanced interventional procedures.
Speciality Intervention
Panther-Rx
- Speciality portfolio device for advanced interventional procedures.
- Designed to support physicians in complex clinical scenarios.
- Part of Freeway’s innovation pipeline for next-generation PCI.
Drug-Eluting Technology
FreeNova-DEB
- Drug-eluting balloon for targeted therapeutic delivery.
- Supports treatment strategies where stent-free intervention is preferred.
- Advancing Freeway’s portfolio in drug-coated interventional solutions.
Innovation Portfolio Overview
- Panther-Rx
- Speciality Portfolio
- FreeNova-DEB
- Drug-Eluting Balloon
Questions?
Talk to the Freeway team.
For product inquiries, partnerships, or clinical information — our team is ready to help.
Contact Us